Cognitive fatigue during a test requiring sustained attention: A pilot study

Multiple Sclerosis

Volumn 9, Issue 5, 2003, Pages 503-508

  Schwid, Steven R ^a   Tyler, Carolyn M ^a   Scheid, Eileen A ^a   Weinstein, Amy ^a   Goodman, Andrew D ^a   McDermott, Michael P ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

Author keywords

Cognition; Fatigue; Multiple sclerosis; Reliability; Validity

Indexed keywords

ADULT; AGE; ANALYTICAL PARAMETERS; ARTICLE; ATTENTION; CLINICAL ARTICLE; CLINICAL PRACTICE; COGNITIVE DEFECT; COMPARATIVE STUDY; CONTROLLED STUDY; CORRELATION ANALYSIS; CORRELATION COEFFICIENT; DISABILITY; EDUCATION; FATIGUE; FEMALE; GENDER; HUMAN; MALE; MENTAL PERFORMANCE; MULTIPLE SCLEROSIS; PILOT STUDY; QUANTITATIVE ANALYSIS; RELIABILITY; SELF REPORT; VALIDATION PROCESS;

ADOLESCENT; ADULT; ATTENTION; COGNITION; FATIGUE; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; NEUROPSYCHOLOGICAL TESTS; PILOT PROJECTS; REPRODUCIBILITY OF RESULTS;

EID: 0142091823     PISSN: 13524585     EISSN: None     Source Type: Journal    
DOI: 10.1191/1352458503ms946oa     Document Type: Article

References (21)

1. Freal JE, Kraft GH, Coryell JK. Symptomatic fatigue in MS. Arch Phys Med Rehabil 1984; 65: 135-38.
2. Krupp LB, Alvarez LA, LaRocca NG, Scheinberg LC. Fatigue in MS. Arch Neurol 1988; 45: 435.
3. Krupp L, LaRocca N, Muir-Nash J, Steinberg A. The fatigue severity scale: Application to patients with MS and systemic lupus erythematosus. Arch Neurol 1989; 46: 1121-23.
4. Fisk JD, Ritvo PG, Ross L, Haase DA, Marrie TJ, Schlech WF. Measuring the functional impact of fatigue: Initial validation of the Fatigue Impact Scale. Clin Inf Dis 1994; 18: S79-S83.
5. Schwid SR, Thornton CA, Pandya S, Manzur LK, Sanjak M, Petrie MD et al. Quantitative assessment of motor fatigue and strength in MS. Neurology 1999; 53: 743-50.
6. Poser CM, Paty DW, Scheinberg L, McDonald WI, Davis FA, Ebers GC et al. New diagnostic criteria for MS: Guidelines for research protocols. Ann Neurol 1983; 13: 227-31.
7. Nyenhuis DL, Luchetta T, Yamamoto C, Terrien A, Bernardin L, Rao SM et al. The development, standardization, and initial validation of the Chicago Multiscale Depression Inventory. J Pers Assess 1998; 70: 386-401.
8. Rao SM, Leo GJ, Benardin L, Unverzagt F. Cognitive dysfunction in MS: 1. Frequency, patterns, and prediction. Neurology 1991; 41: 685-91.
9. Cooper JA, Sagar HJ, Jordan N, Harvey NS, Sullivan EV. Cognitive impairment in early, untreated Parkinson's disease and its relationship to motor disability. Brain 1991; 114: 2095-22.
10. Cohen JA, Fischer JS, Bolibrush DM, Goodman AD, Heidenreich FR, Kooijmans MF et al. Intrarater and interrater reliability of the MS functional composite outcome measure. Neurology 2000; 54: 802-806.
11. Schwid SR, Covington M, Segal BM, Goodman AD. Fatigue in multiple sclerosis: Current understanding and future directions. J Rehabil Res Devel 2002; 39: 211-24.
12. Fleiss JL. The Design and Analysis of Clinical Experiments. New York: John Wiley and Sons, 1986.
13. Murray TJ. Amantadine therapy for fatigue in MS. Can J Neurol Sci 1985; 12: 251-54.
14. Caruso L, LaRocca N, Foley F. Exertional fatigue fails to affect cognitive function in multiple sclerosis. J Clin Exp Neuropsychol 1991; 13: 74.
15. Kujala P, Portin R, Reconsuo A, Ruutiniainen J. Attention related performance in two cognitively different subgroups of patients with MS. J Neurol Neurosurg Psychiatr 1995; 59: 77-82.
16. Johnson S, Guldrun L, DeLuca J, Korn L, Natelson B. The effects of fatigue on neuropsychological performance in patients with chronic fatigue syndrome, MS, and depression. Appl Neuropsychol 1997; 4: 145-53.
17. Paul R, Beatty W, Schneider R, Blanco C, Hames K. Cognitive and physical fatigue in MS: Relations between self-report and objective performance. Appl Neuropsychol 1998; 5: 143-48.
18. Krupp LB, Elkins LE. Fatigue and declines in cognitive functioning in multiple sclerosis. Neurology 2000; 55: 934-39.
19. Kalkers NF, Bergers L, De Groot V, Lazeron RH, Van Walderveen MA, Uitdehaag BM et al. Concurrent validity of the MS Functional Composite using MRI as a biological disease marker. Neurology 2001; 56: 215-19.
20. Hoogervorst EL, Van Winsen LM, Eikelenboom MJ, Kalkers NF, Uitdehaag BM, Polman CH. Comparisons of patient self-report, neurologic examination, and functional impairment in MS. Neurology 2001; 56: 934-37.
21. Taylor R. Relationships between cognitive test performance and everyday cognitive difficulties in multiple sclerosis. Br J Clin Psychol 1990; 29: 251-52.